{"id": "article-22863_0", "title": "Hidradenitis Suppurativa -- Continuing Education Activity", "content": "Hidradenitis suppurativa is a chronic inflammatory skin condition characterized by painful lesions such as deep-seated nodules, abscesses, skin tunnels, and fibrotic scars. These manifestations primarily emerge in intertriginous areas, notably the axillary, groin, perianal, perineal, and inframammary regions.\u00a0The condition's impact extends beyond physical discomfort, with associated pain, drainage, malodor, and scarring often leading to profound negative psychosocial implications for affected individuals.", "contents": "Hidradenitis Suppurativa -- Continuing Education Activity. Hidradenitis suppurativa is a chronic inflammatory skin condition characterized by painful lesions such as deep-seated nodules, abscesses, skin tunnels, and fibrotic scars. These manifestations primarily emerge in intertriginous areas, notably the axillary, groin, perianal, perineal, and inframammary regions.\u00a0The condition's impact extends beyond physical discomfort, with associated pain, drainage, malodor, and scarring often leading to profound negative psychosocial implications for affected individuals."}
{"id": "article-22863_1", "title": "Hidradenitis Suppurativa -- Continuing Education Activity", "content": "The diagnosis\u00a0of hidradenitis suppurativa is clinically based but often challenging and delayed, exacerbating the patient experience. Different grading criteria, including the Hurley classification, are available to guide treatment. Laboratory and imaging tests help characterize the lesions and rule out other conditions.", "contents": "Hidradenitis Suppurativa -- Continuing Education Activity. The diagnosis\u00a0of hidradenitis suppurativa is clinically based but often challenging and delayed, exacerbating the patient experience. Different grading criteria, including the Hurley classification, are available to guide treatment. Laboratory and imaging tests help characterize the lesions and rule out other conditions."}
{"id": "article-22863_2", "title": "Hidradenitis Suppurativa -- Continuing Education Activity", "content": "Treatment involves lifestyle modifications, medications such as antibiotics and anti-inflammatory drugs, procedures like laser therapy and excision\u00a0with\u00a0skin grafting.\u00a0Supportive therapies like pain management and psychological support may also benefit patients.\u00a0Interprofessional\u00a0care\u00a0is crucial to\u00a0creating\u00a0a personalized treatment plan, with regular follow-up appointments to monitor effectiveness and make adjustments as necessary.", "contents": "Hidradenitis Suppurativa -- Continuing Education Activity. Treatment involves lifestyle modifications, medications such as antibiotics and anti-inflammatory drugs, procedures like laser therapy and excision\u00a0with\u00a0skin grafting.\u00a0Supportive therapies like pain management and psychological support may also benefit patients.\u00a0Interprofessional\u00a0care\u00a0is crucial to\u00a0creating\u00a0a personalized treatment plan, with regular follow-up appointments to monitor effectiveness and make adjustments as necessary."}
{"id": "article-22863_3", "title": "Hidradenitis Suppurativa -- Continuing Education Activity", "content": "This\u00a0activity for healthcare professionals is designed to enhance learners' competence in evaluating and managing hidradenitis suppurativa. Participants gain profound insights into the condition's etiology, clinical presentation, complications, and therapeutic strategies. Learners become equipped to collaborate effectively within an interprofessional team to enhance outcomes for individuals with\u00a0hidradenitis suppurativa.", "contents": "Hidradenitis Suppurativa -- Continuing Education Activity. This\u00a0activity for healthcare professionals is designed to enhance learners' competence in evaluating and managing hidradenitis suppurativa. Participants gain profound insights into the condition's etiology, clinical presentation, complications, and therapeutic strategies. Learners become equipped to collaborate effectively within an interprofessional team to enhance outcomes for individuals with\u00a0hidradenitis suppurativa."}
{"id": "article-22863_4", "title": "Hidradenitis Suppurativa -- Continuing Education Activity", "content": "Objectives: Determine the\u00a0potential triggers\u00a0of hidradenitis suppurativa. Identify\u00a0the clinical presentation of hidradenitis suppurativa. Implement an individualized treatment\u00a0plan for\u00a0patients with hidradenitis suppurativa. Apply effective strategies to improve care coordination among interprofessional team members to address complications and comorbidities for patients with\u00a0hidradenitis suppurativa. Access free multiple choice questions on this topic.", "contents": "Hidradenitis Suppurativa -- Continuing Education Activity. Objectives: Determine the\u00a0potential triggers\u00a0of hidradenitis suppurativa. Identify\u00a0the clinical presentation of hidradenitis suppurativa. Implement an individualized treatment\u00a0plan for\u00a0patients with hidradenitis suppurativa. Apply effective strategies to improve care coordination among interprofessional team members to address complications and comorbidities for patients with\u00a0hidradenitis suppurativa. Access free multiple choice questions on this topic."}
{"id": "article-22863_5", "title": "Hidradenitis Suppurativa -- Introduction", "content": "Hidradenitis suppurativa (acne inversa or Verneuil disease)\u00a0is a chronic inflammatory skin condition of follicular occlusion\u00a0with lesions including deep-seated nodules and abscesses, draining\u00a0skin tunnels (also called\u00a0sinus tracts\u00a0or fistulae), and fibrotic scars. [1] [2] These lesions most commonly occur in intertriginous areas,\u00a0though they may present in any location with\u00a0folliculopilosebaceous units.\u00a0The most commonly affected areas are the axillary,\u00a0groin, perianal, perineal, and inframammary\u00a0regions (see Image . Hidradenitis Suppurativa, Left Axilla). [3] [4]", "contents": "Hidradenitis Suppurativa -- Introduction. Hidradenitis suppurativa (acne inversa or Verneuil disease)\u00a0is a chronic inflammatory skin condition of follicular occlusion\u00a0with lesions including deep-seated nodules and abscesses, draining\u00a0skin tunnels (also called\u00a0sinus tracts\u00a0or fistulae), and fibrotic scars. [1] [2] These lesions most commonly occur in intertriginous areas,\u00a0though they may present in any location with\u00a0folliculopilosebaceous units.\u00a0The most commonly affected areas are the axillary,\u00a0groin, perianal, perineal, and inframammary\u00a0regions (see Image . Hidradenitis Suppurativa, Left Axilla). [3] [4]"}
{"id": "article-22863_6", "title": "Hidradenitis Suppurativa -- Introduction", "content": "Treatment varies based on severity and\u00a0may include topical and systemic antibiotics, hormone therapy, immune modulators, and surgery. [5] This condition may have a negative psychosocial impact\u00a0because of the associated pain, involvement of sensitive locations, drainage, odor,\u00a0disfigurement, and scarring. Late diagnosis only worsens the patient experience. [6] [7]", "contents": "Hidradenitis Suppurativa -- Introduction. Treatment varies based on severity and\u00a0may include topical and systemic antibiotics, hormone therapy, immune modulators, and surgery. [5] This condition may have a negative psychosocial impact\u00a0because of the associated pain, involvement of sensitive locations, drainage, odor,\u00a0disfigurement, and scarring. Late diagnosis only worsens the patient experience. [6] [7]"}
{"id": "article-22863_7", "title": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology", "content": "Skin appendages\u00a0include\u00a0the\u00a0pilosebaceous units, sweat glands, and nails, which possess\u00a0distinct functions and histological features.\u00a0The pilosebaceous unit is the assembly formed by the hair shaft, follicle,\u00a0sebaceous gland, and arrector pili muscle. This group of skin appendages develops from the epidermis during fetal development. The hair shaft is visible on the skin's surface and\u00a0is comprised\u00a0of\u00a0cuticle cells surrounding a cortex, with a medulla present in thicker hair. The hair follicle is essential for hair growth and is histologically divided into the infundibulum, isthmus, and inferior segment, with stem cells residing in the bulge area.\u00a0Sebaceous glands are pilosebaceous unit\u00a0components that produce sebum to lubricate hair. These glands have a foamy appearance microscopically due to their lipid content.", "contents": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology. Skin appendages\u00a0include\u00a0the\u00a0pilosebaceous units, sweat glands, and nails, which possess\u00a0distinct functions and histological features.\u00a0The pilosebaceous unit is the assembly formed by the hair shaft, follicle,\u00a0sebaceous gland, and arrector pili muscle. This group of skin appendages develops from the epidermis during fetal development. The hair shaft is visible on the skin's surface and\u00a0is comprised\u00a0of\u00a0cuticle cells surrounding a cortex, with a medulla present in thicker hair. The hair follicle is essential for hair growth and is histologically divided into the infundibulum, isthmus, and inferior segment, with stem cells residing in the bulge area.\u00a0Sebaceous glands are pilosebaceous unit\u00a0components that produce sebum to lubricate hair. These glands have a foamy appearance microscopically due to their lipid content."}
{"id": "article-22863_8", "title": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology", "content": "Sweat glands (sudoriferous glands) are categorized as eccrine or apocrine, which differ in their distribution and secretion mode. Eccrine glands are present in the dermis and upper hypodermis throughout the body and exhibit merocrine secretion, where the cytoplasm remains intact during secretion.\u00a0Apocrine glands\u00a0are\u00a0found in the dermis and subcutanous fat\u00a0in areas like the intertriginous\u00a0zones.\u00a0These glands\u00a0lose\u00a0the top\u00a0portions of the cellular cytoplasm during secretion. Histologically, eccrine glands consist of coiled secretory\u00a0segments\u00a0surrounded by myoepithelial cells, while apocrine glands have less coiling and larger lumens lined by cuboidal epithelial cells.", "contents": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology. Sweat glands (sudoriferous glands) are categorized as eccrine or apocrine, which differ in their distribution and secretion mode. Eccrine glands are present in the dermis and upper hypodermis throughout the body and exhibit merocrine secretion, where the cytoplasm remains intact during secretion.\u00a0Apocrine glands\u00a0are\u00a0found in the dermis and subcutanous fat\u00a0in areas like the intertriginous\u00a0zones.\u00a0These glands\u00a0lose\u00a0the top\u00a0portions of the cellular cytoplasm during secretion. Histologically, eccrine glands consist of coiled secretory\u00a0segments\u00a0surrounded by myoepithelial cells, while apocrine glands have less coiling and larger lumens lined by cuboidal epithelial cells."}
{"id": "article-22863_9", "title": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology", "content": "Nails consist of the nail plate, matrix, eponychium, hyponychium, nail folds, and lunula.\u00a0The matrix\u00a0serves\u00a0as the site of nail formation. The nail plate\u00a0is composed of\u00a0compact keratinocytes and lacks desquamation, contributing to its rigidity and translucency. The hyponychium lies beneath the nail plate, lacks a granular layer, and contains a rich vascular network.\u00a0The eponychium serves as a pathogen barrier. [8]", "contents": "Hidradenitis Suppurativa -- Introduction -- Skin\u00a0Histology. Nails consist of the nail plate, matrix, eponychium, hyponychium, nail folds, and lunula.\u00a0The matrix\u00a0serves\u00a0as the site of nail formation. The nail plate\u00a0is composed of\u00a0compact keratinocytes and lacks desquamation, contributing to its rigidity and translucency. The hyponychium lies beneath the nail plate, lacks a granular layer, and contains a rich vascular network.\u00a0The eponychium serves as a pathogen barrier. [8]"}
{"id": "article-22863_10", "title": "Hidradenitis Suppurativa -- Etiology", "content": "The\u00a0development of\u00a0hidradenitis suppurativa\u00a0appears to have genetic, environmental, and behavioral influences. [9] Approximately 33% to 40% of individuals with hidradenitis suppurativa report an affected first-degree relative, suggesting a hereditary component with an autosomal dominant transmission pattern. [10] Researchers have identified a loss-of-function mutation of the \u03b3-secretase complex involved in the Notch signaling pathway in a small subset of affected families. [11] Other mutations identified in hidradenitis suppurativa include DCD (encoding dermcidin), PSTPIP1\u00a0( found in hidradenitis suppurativa syndromes), SOX9, and KLF5 genes. [12] [13] [14]", "contents": "Hidradenitis Suppurativa -- Etiology. The\u00a0development of\u00a0hidradenitis suppurativa\u00a0appears to have genetic, environmental, and behavioral influences. [9] Approximately 33% to 40% of individuals with hidradenitis suppurativa report an affected first-degree relative, suggesting a hereditary component with an autosomal dominant transmission pattern. [10] Researchers have identified a loss-of-function mutation of the \u03b3-secretase complex involved in the Notch signaling pathway in a small subset of affected families. [11] Other mutations identified in hidradenitis suppurativa include DCD (encoding dermcidin), PSTPIP1\u00a0( found in hidradenitis suppurativa syndromes), SOX9, and KLF5 genes. [12] [13] [14]"}
{"id": "article-22863_11", "title": "Hidradenitis Suppurativa -- Etiology", "content": "Environmental and behavioral factors are vital\u00a0in hidradenitis suppurativa's development. Individuals with\u00a0this condition\u00a0often have comorbidities such as obesity, leading to increased skin friction, sweat production and retention, and hormonal changes, particularly androgen excess. [15] [16] Metabolic syndrome, more prevalent in obesity, is also observed in\u00a0hidradenitis suppurativa cases. [17] Smoking may exacerbate the condition, with nicotine implicated in increasing follicular plugging. [18] [19] As with obesity, disease progression and severity are worse in people who smoke. [20]", "contents": "Hidradenitis Suppurativa -- Etiology. Environmental and behavioral factors are vital\u00a0in hidradenitis suppurativa's development. Individuals with\u00a0this condition\u00a0often have comorbidities such as obesity, leading to increased skin friction, sweat production and retention, and hormonal changes, particularly androgen excess. [15] [16] Metabolic syndrome, more prevalent in obesity, is also observed in\u00a0hidradenitis suppurativa cases. [17] Smoking may exacerbate the condition, with nicotine implicated in increasing follicular plugging. [18] [19] As with obesity, disease progression and severity are worse in people who smoke. [20]"}
{"id": "article-22863_12", "title": "Hidradenitis Suppurativa -- Etiology", "content": "Hormonal influences,\u00a0signified by a higher female preponderance,\u00a0menstrual cycle-related symptom fluctuations, exogenous hormone intake, and pubertal and menopausal links, have been observed. [21] [22] Other potential factors include medications, bacteria, and mechanical friction. [23]", "contents": "Hidradenitis Suppurativa -- Etiology. Hormonal influences,\u00a0signified by a higher female preponderance,\u00a0menstrual cycle-related symptom fluctuations, exogenous hormone intake, and pubertal and menopausal links, have been observed. [21] [22] Other potential factors include medications, bacteria, and mechanical friction. [23]"}
{"id": "article-22863_13", "title": "Hidradenitis Suppurativa -- Epidemiology", "content": "The estimated prevalence of hidradenitis suppurativa ranges from under 1% to 4%. [24] These numbers are likely underestimated because of underreporting and misdiagnosis.\u00a0The condition's onset is commonly between puberty and 40 years, most frequently from ages 21 to 29. Women are about\u00a03 times more affected than men. [25] Racial or ethnic predilection is currently unsupported,\u00a0though the disease\u00a0may be underreported, and studies\u00a0have likely excluded black and Hispanic patients. [26] [27]", "contents": "Hidradenitis Suppurativa -- Epidemiology. The estimated prevalence of hidradenitis suppurativa ranges from under 1% to 4%. [24] These numbers are likely underestimated because of underreporting and misdiagnosis.\u00a0The condition's onset is commonly between puberty and 40 years, most frequently from ages 21 to 29. Women are about\u00a03 times more affected than men. [25] Racial or ethnic predilection is currently unsupported,\u00a0though the disease\u00a0may be underreported, and studies\u00a0have likely excluded black and Hispanic patients. [26] [27]"}
{"id": "article-22863_14", "title": "Hidradenitis Suppurativa -- Pathophysiology", "content": "Hidradenitis suppurativa's pathophysiologic mechanism starts with a defective hair follicle's occlusion and rupture, releasing keratin and bacteria into the surrounding dermis. This occlusion leads to keratinocyte proliferation and an immune response. [28] [29] Neutrophilic and lymphocytic proliferation and heightened activity result in abscess formation and follicular destruction, with the involvement of adjacent tissues. [30] Additional contributors may include abnormal antimicrobial peptides, epidermal invaginations forming tracts, hormonal effects on follicular receptors, and complement pathways.\u00a0Sebaceous glands also become deficient. [31] [32]", "contents": "Hidradenitis Suppurativa -- Pathophysiology. Hidradenitis suppurativa's pathophysiologic mechanism starts with a defective hair follicle's occlusion and rupture, releasing keratin and bacteria into the surrounding dermis. This occlusion leads to keratinocyte proliferation and an immune response. [28] [29] Neutrophilic and lymphocytic proliferation and heightened activity result in abscess formation and follicular destruction, with the involvement of adjacent tissues. [30] Additional contributors may include abnormal antimicrobial peptides, epidermal invaginations forming tracts, hormonal effects on follicular receptors, and complement pathways.\u00a0Sebaceous glands also become deficient. [31] [32]"}
{"id": "article-22863_15", "title": "Hidradenitis Suppurativa -- Pathophysiology", "content": "Immunological abnormalities are evident in hidradenitis suppurativa. Inflammatory cytokines like tumor necrosis factor-\u03b1 and interleukins are elevated in lesions, offering potential treatment targets. [33] [34] [35] While bacteria are not considered the primary cause, these organisms may trigger an inflammatory response. Patients may receive antibiotics for presumed infections, potentially leading to drug-resistant skin flora. [36] Aspirates from unruptured lesions typically yield sterile cultures. Bacterial infection and colonization\u00a0may\u00a0worsen hidradenitis suppurativa.", "contents": "Hidradenitis Suppurativa -- Pathophysiology. Immunological abnormalities are evident in hidradenitis suppurativa. Inflammatory cytokines like tumor necrosis factor-\u03b1 and interleukins are elevated in lesions, offering potential treatment targets. [33] [34] [35] While bacteria are not considered the primary cause, these organisms may trigger an inflammatory response. Patients may receive antibiotics for presumed infections, potentially leading to drug-resistant skin flora. [36] Aspirates from unruptured lesions typically yield sterile cultures. Bacterial infection and colonization\u00a0may\u00a0worsen hidradenitis suppurativa."}
{"id": "article-22863_16", "title": "Hidradenitis Suppurativa -- Histopathology", "content": "Hidradenitis suppurativa\u00a0may be diagnosed clinically,\u00a0but a skin biopsy\u00a0can help confirm\u00a0the diagnosis\u00a0in\u00a0equivocal cases. Hidradenitis suppurativa's histopathological features include: Follicular occlusion Follicular hyperkeratosis Infundibular follicular epithelial hyperplasia Epidermal psoriasiform hyperplasia Keratin plugging Perifolliculitis (predominantly lymphocytic) Plasmocytic infiltrate Pseudoepitheliomatous hyperplasia", "contents": "Hidradenitis Suppurativa -- Histopathology. Hidradenitis suppurativa\u00a0may be diagnosed clinically,\u00a0but a skin biopsy\u00a0can help confirm\u00a0the diagnosis\u00a0in\u00a0equivocal cases. Hidradenitis suppurativa's histopathological features include: Follicular occlusion Follicular hyperkeratosis Infundibular follicular epithelial hyperplasia Epidermal psoriasiform hyperplasia Keratin plugging Perifolliculitis (predominantly lymphocytic) Plasmocytic infiltrate Pseudoepitheliomatous hyperplasia"}
{"id": "article-22863_17", "title": "Hidradenitis Suppurativa -- Histopathology", "content": "Reports on the frequency of finding foreign body and epithelioid granulomas are\u00a0conflicting, with some reporting them as frequent and others as infrequent. Eosinophils may be observed, but this finding is controversial, as studies report\u00a0eosinophilic presence\u00a0inconsistently. [37]", "contents": "Hidradenitis Suppurativa -- Histopathology. Reports on the frequency of finding foreign body and epithelioid granulomas are\u00a0conflicting, with some reporting them as frequent and others as infrequent. Eosinophils may be observed, but this finding is controversial, as studies report\u00a0eosinophilic presence\u00a0inconsistently. [37]"}
{"id": "article-22863_18", "title": "Hidradenitis Suppurativa -- History and Physical", "content": "Hidradenitis suppurativa diagnosis is often delayed by an average of 7 years due to its resemblance to other conditions. Clinical diagnosis involves recognizing characteristic morphological features (nodules, tunnels, and scars), location (intertriginous areas), and chronicity. [38] Half of patients present prodromal symptoms such as burning, stinging, pain, pruritus, warmth, or hyperhidrosis,\u00a0which\u00a0may precede lesion appearance by 12 to 48 hours. [39] Triggers include menstruation, weight gain, stress, hormonal changes, excessive heat, and perspiration. [40] Individuals are usually well-appearing and afebrile at presentation unless secondary infection or advanced disease is present.", "contents": "Hidradenitis Suppurativa -- History and Physical. Hidradenitis suppurativa diagnosis is often delayed by an average of 7 years due to its resemblance to other conditions. Clinical diagnosis involves recognizing characteristic morphological features (nodules, tunnels, and scars), location (intertriginous areas), and chronicity. [38] Half of patients present prodromal symptoms such as burning, stinging, pain, pruritus, warmth, or hyperhidrosis,\u00a0which\u00a0may precede lesion appearance by 12 to 48 hours. [39] Triggers include menstruation, weight gain, stress, hormonal changes, excessive heat, and perspiration. [40] Individuals are usually well-appearing and afebrile at presentation unless secondary infection or advanced disease is present."}
{"id": "article-22863_19", "title": "Hidradenitis Suppurativa -- History and Physical", "content": "Characteristic primary hidradenitis suppurativa lesions are deep-seated nodules, typically 0.5 to 2 cm in size,\u00a0persisting\u00a0for days to months. The lesions are often mistaken for furuncles or boils and may\u00a0have serosanguinous discharge, which can become purulent and malodorous. Unlike furuncles, these nodules are deep, recurrent, rupture-prone, and can form intercommunicating tunnels and tracts that may ulcerate or drain.\u00a0Lidocaine injection or ultrasound examination can\u00a0help visualize these tracts. [41] Advanced stages may feature thick fibrotic scars and plaques, causing architectural distortion and open comedones known as \"tombstone\" comedones. [42]", "contents": "Hidradenitis Suppurativa -- History and Physical. Characteristic primary hidradenitis suppurativa lesions are deep-seated nodules, typically 0.5 to 2 cm in size,\u00a0persisting\u00a0for days to months. The lesions are often mistaken for furuncles or boils and may\u00a0have serosanguinous discharge, which can become purulent and malodorous. Unlike furuncles, these nodules are deep, recurrent, rupture-prone, and can form intercommunicating tunnels and tracts that may ulcerate or drain.\u00a0Lidocaine injection or ultrasound examination can\u00a0help visualize these tracts. [41] Advanced stages may feature thick fibrotic scars and plaques, causing architectural distortion and open comedones known as \"tombstone\" comedones. [42]"}
{"id": "article-22863_20", "title": "Hidradenitis Suppurativa -- History and Physical", "content": "The axilla is the most common location for hidradenitis suppurativa lesions. Other common areas\u00a0include the inguinal, inner thigh, perianal, perineal, inframammary, gluteal, pubic, scrotal, vulvar, and trunk regions.\u00a0The scalp and retroauricular areas are less frequently involved (see Image .\u00a0Hidradenitis Suppurativa, Groin). [43] Pertinent history includes onset typically from puberty to young adulthood, with recurrent lesions and intermittent improvement. A family history of a similar condition aids in diagnosis confirmation. Once the history and physical exam are complete, the Hurley staging system\u00a0may\u00a0be used to\u00a0classify the disease. This system categorizes lesions as follows:", "contents": "Hidradenitis Suppurativa -- History and Physical. The axilla is the most common location for hidradenitis suppurativa lesions. Other common areas\u00a0include the inguinal, inner thigh, perianal, perineal, inframammary, gluteal, pubic, scrotal, vulvar, and trunk regions.\u00a0The scalp and retroauricular areas are less frequently involved (see Image .\u00a0Hidradenitis Suppurativa, Groin). [43] Pertinent history includes onset typically from puberty to young adulthood, with recurrent lesions and intermittent improvement. A family history of a similar condition aids in diagnosis confirmation. Once the history and physical exam are complete, the Hurley staging system\u00a0may\u00a0be used to\u00a0classify the disease. This system categorizes lesions as follows:"}
{"id": "article-22863_21", "title": "Hidradenitis Suppurativa -- History and Physical", "content": "Hurley Stage I: Abscesses\u00a0lack\u00a0tunnels\u00a0and\u00a0scars. Hurley Stage II: Recurrent abscesses\u00a0have\u00a0tunnels and scars,\u00a0and the lesions\u00a0may be single or multiple but widely separated. Hurley Stage III: Lesions\u00a0diffusely involve\u00a0the skin,\u00a0ie, multiple interconnected sinus tracts are present, and abscesses\u00a0occupy\u00a0large\u00a0areas, leaving little to no uninvolved skin (see Image .\u00a0Hidradenitis Suppurativa, Suprapubic Region). [44]", "contents": "Hidradenitis Suppurativa -- History and Physical. Hurley Stage I: Abscesses\u00a0lack\u00a0tunnels\u00a0and\u00a0scars. Hurley Stage II: Recurrent abscesses\u00a0have\u00a0tunnels and scars,\u00a0and the lesions\u00a0may be single or multiple but widely separated. Hurley Stage III: Lesions\u00a0diffusely involve\u00a0the skin,\u00a0ie, multiple interconnected sinus tracts are present, and abscesses\u00a0occupy\u00a0large\u00a0areas, leaving little to no uninvolved skin (see Image .\u00a0Hidradenitis Suppurativa, Suprapubic Region). [44]"}
{"id": "article-22863_22", "title": "Hidradenitis Suppurativa -- History and Physical", "content": "Hidradenitis suppurativa is\u00a0a component of the follicular occlusion tetrad, along with acne conglobata, dissecting scalp cellulitis, and pilonidal sinus. [45] A diagnosis of hidradenitis suppurativa should prompt evaluation for\u00a0possible cooccurrence of these conditions. Clinicians should also consider associations with metabolic syndrome, dyslipidemia, hypertension, diabetes mellitus, inflammatory bowel disease (especially Crohn disease), and spondyloarthropathy during assessment. [46] Syndromes like pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PAPASH) and pyoderma gangrenosum, acne suppurative hidradenitis (PASH), possibly\u00a0related to a PSTPIP1 gene mutation, also warrant attention. [47]", "contents": "Hidradenitis Suppurativa -- History and Physical. Hidradenitis suppurativa is\u00a0a component of the follicular occlusion tetrad, along with acne conglobata, dissecting scalp cellulitis, and pilonidal sinus. [45] A diagnosis of hidradenitis suppurativa should prompt evaluation for\u00a0possible cooccurrence of these conditions. Clinicians should also consider associations with metabolic syndrome, dyslipidemia, hypertension, diabetes mellitus, inflammatory bowel disease (especially Crohn disease), and spondyloarthropathy during assessment. [46] Syndromes like pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PAPASH) and pyoderma gangrenosum, acne suppurative hidradenitis (PASH), possibly\u00a0related to a PSTPIP1 gene mutation, also warrant attention. [47]"}
{"id": "article-22863_23", "title": "Hidradenitis Suppurativa -- Evaluation", "content": "Hidradenitis suppurativa is a clinical diagnosis. No biological or pathological diagnostic tests are required to confirm the condition. However, a biopsy may help\u00a0rule out squamous cell carcinoma if the diagnosis is uncertain. Bacterial cultures are not\u00a0beneficial\u00a0unless a secondary infection or an alternative diagnosis is suspected. Imaging is not typically helpful, though\u00a0ultrasonography\u00a0may\u00a0help identify skin tunneling\u00a0preoperatively. [48] Severe perianal disease may warrant further imaging, preferably by magnetic resonance imaging. [49]", "contents": "Hidradenitis Suppurativa -- Evaluation. Hidradenitis suppurativa is a clinical diagnosis. No biological or pathological diagnostic tests are required to confirm the condition. However, a biopsy may help\u00a0rule out squamous cell carcinoma if the diagnosis is uncertain. Bacterial cultures are not\u00a0beneficial\u00a0unless a secondary infection or an alternative diagnosis is suspected. Imaging is not typically helpful, though\u00a0ultrasonography\u00a0may\u00a0help identify skin tunneling\u00a0preoperatively. [48] Severe perianal disease may warrant further imaging, preferably by magnetic resonance imaging. [49]"}
{"id": "article-22863_24", "title": "Hidradenitis Suppurativa -- Evaluation", "content": "Guidelines recommend additional investigations to assess comorbid conditions in patients with hidradenitis suppurativa. Assessments typically involve annual physical examinations, validated screening tools,\u00a0and laboratory tests. Referrals to specialists familiar with associated conditions may be necessary for further evaluation. Comorbidities in patients with hidradenitis suppurativa may include the following:", "contents": "Hidradenitis Suppurativa -- Evaluation. Guidelines recommend additional investigations to assess comorbid conditions in patients with hidradenitis suppurativa. Assessments typically involve annual physical examinations, validated screening tools,\u00a0and laboratory tests. Referrals to specialists familiar with associated conditions may be necessary for further evaluation. Comorbidities in patients with hidradenitis suppurativa may include the following:"}
{"id": "article-22863_25", "title": "Hidradenitis Suppurativa -- Evaluation", "content": "Acne vulgaris or acne conglobata Dissecting cellulitis of the scalp Pilonidal cyst Pyoderma gangrenosum Depression Anxiety Suicidality Tobacco use disorder Substance use disorder Polycystic ovarian syndrome Obesity Dyslipidemia Diabetes mellitus Metabolic syndrome Hypertension Cardiovascular disease Inflammatory bowel disease SAPHO syndrome Behcet syndrome Spondyloarthritis Sexual dysfunction Down syndrome Thyroid disease Nonalcoholic fatty liver disease Obstructive sleep apnea Renal disease Sleep disturbances Alzheimer disease Herpes zoster Lymphoma Psoriasis vulgaris Pachyonychia congenita Dowling-Degos disease KID syndrome Stroke Anemia Cutaneous squamous cell carcinoma\u00a0: [50] [51]", "contents": "Hidradenitis Suppurativa -- Evaluation. Acne vulgaris or acne conglobata Dissecting cellulitis of the scalp Pilonidal cyst Pyoderma gangrenosum Depression Anxiety Suicidality Tobacco use disorder Substance use disorder Polycystic ovarian syndrome Obesity Dyslipidemia Diabetes mellitus Metabolic syndrome Hypertension Cardiovascular disease Inflammatory bowel disease SAPHO syndrome Behcet syndrome Spondyloarthritis Sexual dysfunction Down syndrome Thyroid disease Nonalcoholic fatty liver disease Obstructive sleep apnea Renal disease Sleep disturbances Alzheimer disease Herpes zoster Lymphoma Psoriasis vulgaris Pachyonychia congenita Dowling-Degos disease KID syndrome Stroke Anemia Cutaneous squamous cell carcinoma\u00a0: [50] [51]"}
{"id": "article-22863_26", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "The overall treatment goals for hidradenitis suppurativa include alleviating lesion-related symptoms (eg, pain), reducing recurrence frequency and new lesion formation, and preventing disease and comorbidity progression.\u00a0Treatment approaches are largely based on expert opinion and consensus\u00a0due to limited comparative studies.", "contents": "Hidradenitis Suppurativa -- Treatment / Management. The overall treatment goals for hidradenitis suppurativa include alleviating lesion-related symptoms (eg, pain), reducing recurrence frequency and new lesion formation, and preventing disease and comorbidity progression.\u00a0Treatment approaches are largely based on expert opinion and consensus\u00a0due to limited comparative studies."}
{"id": "article-22863_27", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Treatment response assessment involves monitoring lesion frequency, severity, extent, and morphology.\u00a0Quality of life changes are also evaluated using validated tools, and progression to associated comorbidities is assessed. Various scales and scoring systems, including the International Hidradenitis Suppurativa Severity Scoring System, Sartorius score,\u00a0Hidradenitis\u00a0Suppurativa\u00a0Physician\u00a0Global\u00a0Assessment, and\u00a0Hidradenitis\u00a0Suppurativa\u00a0Core\u00a0Outcome\u00a0Set\u00a0International\u00a0Collaboration, are used to measure\u00a0the condition's severity and treatment outcomes. [52] [53] [54]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Treatment response assessment involves monitoring lesion frequency, severity, extent, and morphology.\u00a0Quality of life changes are also evaluated using validated tools, and progression to associated comorbidities is assessed. Various scales and scoring systems, including the International Hidradenitis Suppurativa Severity Scoring System, Sartorius score,\u00a0Hidradenitis\u00a0Suppurativa\u00a0Physician\u00a0Global\u00a0Assessment, and\u00a0Hidradenitis\u00a0Suppurativa\u00a0Core\u00a0Outcome\u00a0Set\u00a0International\u00a0Collaboration, are used to measure\u00a0the condition's severity and treatment outcomes. [52] [53] [54]"}
{"id": "article-22863_28", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Hidradenitis suppurativa\u00a0treatment should address comorbidities contributing to disease development or worsening, regardless of disease stage. Counseling and support for weight loss and smoking cessation are crucial, as obesity and smoking are associated with more severe disease progression. Minimizing skin trauma is also essential, achieved by avoiding tight clothing, harsh cleaning products, and adhesive dressings. Soft dressings with clear petroleum jelly or nonocclusive dressings can help prevent further irritation to draining lesions. [55]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Hidradenitis suppurativa\u00a0treatment should address comorbidities contributing to disease development or worsening, regardless of disease stage. Counseling and support for weight loss and smoking cessation are crucial, as obesity and smoking are associated with more severe disease progression. Minimizing skin trauma is also essential, achieved by avoiding tight clothing, harsh cleaning products, and adhesive dressings. Soft dressings with clear petroleum jelly or nonocclusive dressings can help prevent further irritation to draining lesions. [55]"}
{"id": "article-22863_29", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Patients with hidradenitis suppurativa should\u00a0be thoroughly\u00a0educated\u00a0about\u00a0the condition's nature, wound care, and pain management. Individualized pain management plans must address potential inpatient admissions. [56] [57] Hidradenitis suppurativa-related pain stems from both inflammatory and noninflammatory sources,\u00a0including scarring\u00a0(causing tensile pain), keloids, abscesses, open ulcerations, sinus tracts, frictional pain, lymphedema, anal fissures, and arthritis. Treatments may include topical agents like lidocaine, systemic nonsteroidal anti-inflammatory drugs, acetaminophen, atypical anticonvulsants such as gabapentin or pregabalin, and serotonin-norepinephrine reuptake inhibitors, depending on disease severity and pain type. Duloxetine may be particularly beneficial for patients with comorbid depression. [58] [59]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Patients with hidradenitis suppurativa should\u00a0be thoroughly\u00a0educated\u00a0about\u00a0the condition's nature, wound care, and pain management. Individualized pain management plans must address potential inpatient admissions. [56] [57] Hidradenitis suppurativa-related pain stems from both inflammatory and noninflammatory sources,\u00a0including scarring\u00a0(causing tensile pain), keloids, abscesses, open ulcerations, sinus tracts, frictional pain, lymphedema, anal fissures, and arthritis. Treatments may include topical agents like lidocaine, systemic nonsteroidal anti-inflammatory drugs, acetaminophen, atypical anticonvulsants such as gabapentin or pregabalin, and serotonin-norepinephrine reuptake inhibitors, depending on disease severity and pain type. Duloxetine may be particularly beneficial for patients with comorbid depression. [58] [59]"}
{"id": "article-22863_30", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "A critically important but often overlooked aspect of treatment involves hidradenitis suppurativa's psychosocial aspect. Pain, drainage, odor, and involvement of sensitive areas reduce patients' quality of life. [60] Individuals\u00a0with\u00a0this condition may experience social isolation, employment\u00a0difficulties due to missed work during flares, and heightened sexual or relationship dysfunction. [61] Assurance that this condition is not contagious or the result of\u00a0poor hygiene can be helpful. Counseling and support groups are often beneficial additions to therapeutic plans. [62] Treatment for acute symptomatic lesions may include intralesional corticosteroid injection (usually triamcinolone), punch debridement,\u00a0and topical resorcinol. [63] [64] [65] Incision and drainage is not recommended. [66]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. A critically important but often overlooked aspect of treatment involves hidradenitis suppurativa's psychosocial aspect. Pain, drainage, odor, and involvement of sensitive areas reduce patients' quality of life. [60] Individuals\u00a0with\u00a0this condition may experience social isolation, employment\u00a0difficulties due to missed work during flares, and heightened sexual or relationship dysfunction. [61] Assurance that this condition is not contagious or the result of\u00a0poor hygiene can be helpful. Counseling and support groups are often beneficial additions to therapeutic plans. [62] Treatment for acute symptomatic lesions may include intralesional corticosteroid injection (usually triamcinolone), punch debridement,\u00a0and topical resorcinol. [63] [64] [65] Incision and drainage is not recommended. [66]"}
{"id": "article-22863_31", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Topical antibiotics are the first-line treatment for early uncomplicated disease.\u00a0Topical clindamycin has been proven the most effective\u00a0and may\u00a0be an appropriate adjunctive treatment to oral therapy. [67] Hurley stage I disease\u00a0without skin tunneling or scarring\u00a0may be treated with oral tetracycline antibiotics (eg, doxycycline), antiandrogen agents (eg, spironolactone),\u00a0and metformin. [68] Tetracyclines should be discontinued and other agents retained if\u00a0patient\u00a0response is satisfactory after 2 to 3 months.\u00a0Another tetracycline\u00a0trial should be initiated if improvement occurs but is unsatisfactory. Switching to a combination of oral clindamycin and rifampin, dapsone, or acitretin may be\u00a0considered if the clinical response remains unsatisfactory after 2 to 3 months on the same regimen or a\u00a02nd tetracycline\u00a0trial. [69] [70]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Topical antibiotics are the first-line treatment for early uncomplicated disease.\u00a0Topical clindamycin has been proven the most effective\u00a0and may\u00a0be an appropriate adjunctive treatment to oral therapy. [67] Hurley stage I disease\u00a0without skin tunneling or scarring\u00a0may be treated with oral tetracycline antibiotics (eg, doxycycline), antiandrogen agents (eg, spironolactone),\u00a0and metformin. [68] Tetracyclines should be discontinued and other agents retained if\u00a0patient\u00a0response is satisfactory after 2 to 3 months.\u00a0Another tetracycline\u00a0trial should be initiated if improvement occurs but is unsatisfactory. Switching to a combination of oral clindamycin and rifampin, dapsone, or acitretin may be\u00a0considered if the clinical response remains unsatisfactory after 2 to 3 months on the same regimen or a\u00a02nd tetracycline\u00a0trial. [69] [70]"}
{"id": "article-22863_32", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "The initial treatment for Hurley stages II and III is similar to that of Hurley stage I disease.\u00a0Potential treatment reactions must be considered during therapeutic planning.\u00a0Patients\u00a0should be educated on these medications' adverse effects\u00a0before starting their regimen.", "contents": "Hidradenitis Suppurativa -- Treatment / Management. The initial treatment for Hurley stages II and III is similar to that of Hurley stage I disease.\u00a0Potential treatment reactions must be considered during therapeutic planning.\u00a0Patients\u00a0should be educated on these medications' adverse effects\u00a0before starting their regimen."}
{"id": "article-22863_33", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Surgical\u00a0or biologic therapy should be considered if the patient poorly responds after 2 to 3 months of initial therapy,\u00a0fails a 2- to 3-month second therapeutic trial, or a Hurley stage I case is treatment-refractory. [71]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Surgical\u00a0or biologic therapy should be considered if the patient poorly responds after 2 to 3 months of initial therapy,\u00a0fails a 2- to 3-month second therapeutic trial, or a Hurley stage I case is treatment-refractory. [71]"}
{"id": "article-22863_34", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "The preferred biologic agent for hidradenitis suppurativa is adalimumab, as it is backed by extensive research. Secukinumab, infliximab, or acitretin are alternatives.\u00a0Etanercept has not shown efficacy in treating this condition. [72] [73] [74] The treatment must be continued if the patient demonstrates\u00a0progressive improvement after 3 to 4 months of biologic therapy. Oral antiandrogen agents and metformin may be used as adjuncts. [75]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. The preferred biologic agent for hidradenitis suppurativa is adalimumab, as it is backed by extensive research. Secukinumab, infliximab, or acitretin are alternatives.\u00a0Etanercept has not shown efficacy in treating this condition. [72] [73] [74] The treatment must be continued if the patient demonstrates\u00a0progressive improvement after 3 to 4 months of biologic therapy. Oral antiandrogen agents and metformin may be used as adjuncts. [75]"}
{"id": "article-22863_35", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Switching to a different class of biologics is advised if the response is unsatisfactory,\u00a0followed by\u00a0reassessment\u00a0in 3 to 4 months for continued treatment or consideration of alternatives. [76] [77] Surgical management and adjunctive therapies like intravenous ertapenem may be considered for severe, refractory hidradenitis suppurativa. Localized laser and pulsed light therapy may be offered as an option\u00a0to disrupt the inflammatory process. [78] [79] [80]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Switching to a different class of biologics is advised if the response is unsatisfactory,\u00a0followed by\u00a0reassessment\u00a0in 3 to 4 months for continued treatment or consideration of alternatives. [76] [77] Surgical management and adjunctive therapies like intravenous ertapenem may be considered for severe, refractory hidradenitis suppurativa. Localized laser and pulsed light therapy may be offered as an option\u00a0to disrupt the inflammatory process. [78] [79] [80]"}
{"id": "article-22863_36", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Surgical management may be pursued at any stage to remove areas of active disease and limit complications, but it should be combined with\u00a0medical therapy.\u00a0Preoperative management should include antibiotics, anti-inflammatory\u00a0agents (eg, biologics or cyclosporine), and\u00a0corticosteroids (eg, prednisone or glucocorticoids). [81] Local procedures include punch debridement, deroofing, or wide excision. Punch debridement uses a 5- to 7-mm\u00a0circular punch biopsy tool to evacuate an inflamed lesion.\u00a0The lesion is left to heal by secondary intention with a petrolatum dressing\u00a0after achieving hemostasis.\u00a0Deroofing involves entering skin tunnels and sequentially removing their roofs using scissors or a carbon dioxide laser. [82]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Surgical management may be pursued at any stage to remove areas of active disease and limit complications, but it should be combined with\u00a0medical therapy.\u00a0Preoperative management should include antibiotics, anti-inflammatory\u00a0agents (eg, biologics or cyclosporine), and\u00a0corticosteroids (eg, prednisone or glucocorticoids). [81] Local procedures include punch debridement, deroofing, or wide excision. Punch debridement uses a 5- to 7-mm\u00a0circular punch biopsy tool to evacuate an inflamed lesion.\u00a0The lesion is left to heal by secondary intention with a petrolatum dressing\u00a0after achieving hemostasis.\u00a0Deroofing involves entering skin tunnels and sequentially removing their roofs using scissors or a carbon dioxide laser. [82]"}
{"id": "article-22863_37", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Wide excision with reconstruction may be\u00a0performed\u00a0to debride a lesion\u00a0until\u00a0only the subcutaneous fat remains. Primary closure or a larger flap\u00a0may be used for repair, depending on the anatomic location. [83] Grafting, which involves debriding the affected subepidermal skin and recycling the epidermis as a skin graft, may also be considered. Negative pressure wound therapy has also been used. [84] Petrolatum\u00a0nonadherent dressings\u00a0are recommended\u00a0postoperatively to avoid friction.\u00a0However,\u00a0patients should be cautioned about the risks of bleeding, infection, or new disease when using these dressings. [85]", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Wide excision with reconstruction may be\u00a0performed\u00a0to debride a lesion\u00a0until\u00a0only the subcutaneous fat remains. Primary closure or a larger flap\u00a0may be used for repair, depending on the anatomic location. [83] Grafting, which involves debriding the affected subepidermal skin and recycling the epidermis as a skin graft, may also be considered. Negative pressure wound therapy has also been used. [84] Petrolatum\u00a0nonadherent dressings\u00a0are recommended\u00a0postoperatively to avoid friction.\u00a0However,\u00a0patients should be cautioned about the risks of bleeding, infection, or new disease when using these dressings. [85]"}
{"id": "article-22863_38", "title": "Hidradenitis Suppurativa -- Treatment / Management", "content": "Other therapies that may be considered include neodymium-doped yttrium aluminum garnet (Nd:YAG)\u00a0laser, ustekinumab, anakinra, bimekizumab, guselkumab, canakinumab, cyclosporine, tacrolimus, apremilast, zinc, photodynamic therapy, golimumab, risankizumab, liraglutide, microwave ablation (not currently recommended), cryoinsufflation, botulinum toxin injections, and ionizing radiation.", "contents": "Hidradenitis Suppurativa -- Treatment / Management. Other therapies that may be considered include neodymium-doped yttrium aluminum garnet (Nd:YAG)\u00a0laser, ustekinumab, anakinra, bimekizumab, guselkumab, canakinumab, cyclosporine, tacrolimus, apremilast, zinc, photodynamic therapy, golimumab, risankizumab, liraglutide, microwave ablation (not currently recommended), cryoinsufflation, botulinum toxin injections, and ionizing radiation."}
{"id": "article-22863_39", "title": "Hidradenitis Suppurativa -- Differential Diagnosis", "content": "The\u00a0following conditions should be ruled out\u00a0when diagnosing hidradenitis suppurativa: Follicular pyoderma (including folliculitis, furuncles, and\u00a0carbuncles) Granuloma inguinale Noduloulcerative syphilis Tuberculous abscess Actinomycosis Lymphogranuloma venereum Acne vulgaris Epidermoid, dermoid, pilonidal, or Bartholin cysts Crohn\u00a0disease (particularly with perianal involvement) The following conditions should also be included in the differential diagnosis\u00a0due to similar\u00a0histopathology: Granulomatous diseases (Crohn\u00a0disease, sarcoidosis,\u00a0mycobacterial infection) Chronic deep folliculitis Langerhans cell histiocytosis Folliculotropic mycosis fungoides Crohn disease Pyoderma gangrenosum Follicular rupture Abscess [86] [87] [88]", "contents": "Hidradenitis Suppurativa -- Differential Diagnosis. The\u00a0following conditions should be ruled out\u00a0when diagnosing hidradenitis suppurativa: Follicular pyoderma (including folliculitis, furuncles, and\u00a0carbuncles) Granuloma inguinale Noduloulcerative syphilis Tuberculous abscess Actinomycosis Lymphogranuloma venereum Acne vulgaris Epidermoid, dermoid, pilonidal, or Bartholin cysts Crohn\u00a0disease (particularly with perianal involvement) The following conditions should also be included in the differential diagnosis\u00a0due to similar\u00a0histopathology: Granulomatous diseases (Crohn\u00a0disease, sarcoidosis,\u00a0mycobacterial infection) Chronic deep folliculitis Langerhans cell histiocytosis Folliculotropic mycosis fungoides Crohn disease Pyoderma gangrenosum Follicular rupture Abscess [86] [87] [88]"}
{"id": "article-22863_40", "title": "Hidradenitis Suppurativa -- Prognosis", "content": "The prognosis of\u00a0hidradenitis suppurativa is variable.\u00a0The condition\u00a0is incurable and\u00a0has a chronic, relapsing course. [89] Diagnostic and treatment delays early in the disease course and comorbid conditions\u00a0like smoking and obesity\u00a0often worsen the prognosis. [90] Hurley stage III disease has the worst prognosis, but early recognition can help prevent complications.", "contents": "Hidradenitis Suppurativa -- Prognosis. The prognosis of\u00a0hidradenitis suppurativa is variable.\u00a0The condition\u00a0is incurable and\u00a0has a chronic, relapsing course. [89] Diagnostic and treatment delays early in the disease course and comorbid conditions\u00a0like smoking and obesity\u00a0often worsen the prognosis. [90] Hurley stage III disease has the worst prognosis, but early recognition can help prevent complications."}
{"id": "article-22863_41", "title": "Hidradenitis Suppurativa -- Complications", "content": "Hidradenitis suppurativa has both physical and psychological\u00a0complications. [91] Hidradenitis suppurativa\u00a0recurrence\u00a0may result in chronic pain, limb contractures, and impaired mobility from abscesses, tunnels, and scarring. Lymphatic obstruction may cause peripheral lymphedema. [92] Chronic inflammation's\u00a0long-term effects\u00a0include anemia, hyperproteinemia, amyloidosis, and axial and peripheral arthropathy. [93] Superimposed infections\u00a0may result in systemic illness.\u00a0Squamous cell carcinoma may develop, sometimes\u00a0up to 30 years after diagnosis. [94]", "contents": "Hidradenitis Suppurativa -- Complications. Hidradenitis suppurativa has both physical and psychological\u00a0complications. [91] Hidradenitis suppurativa\u00a0recurrence\u00a0may result in chronic pain, limb contractures, and impaired mobility from abscesses, tunnels, and scarring. Lymphatic obstruction may cause peripheral lymphedema. [92] Chronic inflammation's\u00a0long-term effects\u00a0include anemia, hyperproteinemia, amyloidosis, and axial and peripheral arthropathy. [93] Superimposed infections\u00a0may result in systemic illness.\u00a0Squamous cell carcinoma may develop, sometimes\u00a0up to 30 years after diagnosis. [94]"}
{"id": "article-22863_42", "title": "Hidradenitis Suppurativa -- Complications", "content": "Observational data suggests an increased risk of buccal and hepatocellular cancer. [95] Hidradenitis suppurativa's psychological impact includes depression, social isolation, decreased relationship satisfaction, sexual dysfunction, reduced work productivity, and in extreme cases, suicide.", "contents": "Hidradenitis Suppurativa -- Complications. Observational data suggests an increased risk of buccal and hepatocellular cancer. [95] Hidradenitis suppurativa's psychological impact includes depression, social isolation, decreased relationship satisfaction, sexual dysfunction, reduced work productivity, and in extreme cases, suicide."}
{"id": "article-22863_43", "title": "Hidradenitis Suppurativa -- Deterrence and Patient Education", "content": "Patient education should include reassuring individuals that\u00a0hidradenitis suppurativa\u00a0is not contagious or due to poor hygiene. Prompt reporting of lesions is advised to initiate timely treatment and prevent chronic progression . Lifestyle modifications, such as maintaining a healthy weight, quitting smoking, and avoiding skin trauma\u00a0(eg, by avoiding tight clothing, abrasive cleansers, and adhesive bandages), should be discussed. Patients should also receive information on the risks and benefits of available treatments, with the\u00a0most effective therapy for their current disease state recommended. Psychosocial education and treatment are likewise essential components of care.", "contents": "Hidradenitis Suppurativa -- Deterrence and Patient Education. Patient education should include reassuring individuals that\u00a0hidradenitis suppurativa\u00a0is not contagious or due to poor hygiene. Prompt reporting of lesions is advised to initiate timely treatment and prevent chronic progression . Lifestyle modifications, such as maintaining a healthy weight, quitting smoking, and avoiding skin trauma\u00a0(eg, by avoiding tight clothing, abrasive cleansers, and adhesive bandages), should be discussed. Patients should also receive information on the risks and benefits of available treatments, with the\u00a0most effective therapy for their current disease state recommended. Psychosocial education and treatment are likewise essential components of care."}
{"id": "article-22863_44", "title": "Hidradenitis Suppurativa -- Pearls and Other Issues", "content": "Hidradenitis suppurativa is a non-contagious chronic inflammatory skin disorder characterized by painful nodules, abscesses, and scarring. The condition starts to develop\u00a0with hair follicle blockage, followed by rupture and inflammation.\u00a0Hidradenitis suppurativa is not caused by infection or poor hygiene. Genetic and environmental elements contribute to its pathophysiology, with obesity and smoking being key factors.", "contents": "Hidradenitis Suppurativa -- Pearls and Other Issues. Hidradenitis suppurativa is a non-contagious chronic inflammatory skin disorder characterized by painful nodules, abscesses, and scarring. The condition starts to develop\u00a0with hair follicle blockage, followed by rupture and inflammation.\u00a0Hidradenitis suppurativa is not caused by infection or poor hygiene. Genetic and environmental elements contribute to its pathophysiology, with obesity and smoking being key factors."}
{"id": "article-22863_45", "title": "Hidradenitis Suppurativa -- Pearls and Other Issues", "content": "Treatment options include medications (topical and oral antibiotics, intralesional and oral steroids, hormone therapy, and immune modulators) and surgery, ranging from lesion deroofing to wide excision. Hidradenitis suppurativa can cause significant psychosocial distress due to pain, drainage, odor, and\u00a0involvement of\u00a0sensitive or exposed areas. Early recognition and aggressive treatment offer the best prognosis, including psychosocial support.", "contents": "Hidradenitis Suppurativa -- Pearls and Other Issues. Treatment options include medications (topical and oral antibiotics, intralesional and oral steroids, hormone therapy, and immune modulators) and surgery, ranging from lesion deroofing to wide excision. Hidradenitis suppurativa can cause significant psychosocial distress due to pain, drainage, odor, and\u00a0involvement of\u00a0sensitive or exposed areas. Early recognition and aggressive treatment offer the best prognosis, including psychosocial support."}
{"id": "article-22863_46", "title": "Hidradenitis Suppurativa -- Enhancing Healthcare Team Outcomes", "content": "Hidradenitis suppurativa is a complex condition with numerous comorbidities, requiring an interprofessional approach for effective management. [96] While\u00a0this disorder is primarily a dermatologic concern, individuals may first seek care from various healthcare providers, such as family medicine, internal medicine, pediatrics, or obstetrics/gynecology. Primary care providers are crucial in early recognition and treatment initiation based on lesion characteristics. Depending on disease severity and provider training, primary care providers may manage the condition independently or refer to specialists like dermatologists, surgeons, wound care, and pain management experts.", "contents": "Hidradenitis Suppurativa -- Enhancing Healthcare Team Outcomes. Hidradenitis suppurativa is a complex condition with numerous comorbidities, requiring an interprofessional approach for effective management. [96] While\u00a0this disorder is primarily a dermatologic concern, individuals may first seek care from various healthcare providers, such as family medicine, internal medicine, pediatrics, or obstetrics/gynecology. Primary care providers are crucial in early recognition and treatment initiation based on lesion characteristics. Depending on disease severity and provider training, primary care providers may manage the condition independently or refer to specialists like dermatologists, surgeons, wound care, and pain management experts."}
{"id": "article-22863_47", "title": "Hidradenitis Suppurativa -- Enhancing Healthcare Team Outcomes", "content": "The involvement of multiple healthcare team members, including professionals in the allied health sciences like nurses and pharmacists, may be necessary due to hidradenitis suppurativa's associated comorbidities. Nurses offer counseling, aid in history and examination, and\u00a0act as liaisons\u00a0between patients and clinicians. Pharmacists ensure correct dosing, check for interactions, and educate patients on medication use.\u00a0Mental health providers should be part of the team, including psychiatrists, psychologists, or counselors,\u00a0given the condition's significant psychosocial impact.\u00a0Accurate documentation by all team members is crucial for consistent patient care. Open communication is essential for addressing any issues promptly. This interprofessional approach enhances patient outcomes.", "contents": "Hidradenitis Suppurativa -- Enhancing Healthcare Team Outcomes. The involvement of multiple healthcare team members, including professionals in the allied health sciences like nurses and pharmacists, may be necessary due to hidradenitis suppurativa's associated comorbidities. Nurses offer counseling, aid in history and examination, and\u00a0act as liaisons\u00a0between patients and clinicians. Pharmacists ensure correct dosing, check for interactions, and educate patients on medication use.\u00a0Mental health providers should be part of the team, including psychiatrists, psychologists, or counselors,\u00a0given the condition's significant psychosocial impact.\u00a0Accurate documentation by all team members is crucial for consistent patient care. Open communication is essential for addressing any issues promptly. This interprofessional approach enhances patient outcomes."}
{"id": "article-22863_48", "title": "Hidradenitis Suppurativa -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Hidradenitis Suppurativa -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}